Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $1.01 Million - $1.32 Million
25,000 Added 62.5%
65,000 $2.7 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $1.92 Million - $2.18 Million
40,000 New
40,000 $2.17 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $2.42 Million - $2.89 Million
-50,000 Reduced 55.56%
40,000 $2.05 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $5.73 Million - $6.37 Million
90,000 New
90,000 $5.76 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $9.54 Million - $11.2 Million
-174,100 Reduced 79.28%
45,500 $2.6 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $13.3 Million - $19.3 Million
-285,900 Reduced 56.56%
219,600 $12 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $14.7 Million - $19.1 Million
298,100 Added 143.73%
505,500 $31.2 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $4.28 Million - $5.07 Million
-100,000 Reduced 32.53%
207,400 $10.4 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $42.6 Million - $47.1 Million
-955,300 Reduced 75.66%
307,400 $14.2 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $48.6 Million - $58 Million
1,077,700 Added 582.54%
1,262,700 $59.6 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $10.2 Million - $11.8 Million
185,000
185,000 $11.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.